Ambar is our Americas Life Sciences Stratégie et Transactions Leader. He advises life sciences and health care clients on their capital and transaction agendas from strategy through execution, primarily focusing on large, complex investments.
Over the last 20 years, he has supported private equity funds and corporate clients in transformational stratégie et transactions to realize their strategic objectives and improve growth.
His experience includes financial and operational diligence in taking companies private, leveraged recapitalizations, carve-outs, rollups, divestitures, PIPE and public financing. He has worked extensively in the UK and the US, and has led global engagements with our clients and transaction teams in Europe, India, the Middle East and Asia.
Ambar obtained his BSc with honors in Economics from the London School of Economics and Political Science. He is a fellow of the Institute of Chartered Accountants in England and Wales and a Chartered Financial Analyst charter holder.
How Ambar is building a better working world
“I work with pharma, medical device and biotech companies to optimize their existing portfolios and address the megatrends that impact the life sciences sector. My understanding of the industry issues and connectivity to the broader healthcare ecosystem inspire me to ask better questions. I then work with my teams and clients to create innovative approaches.”